Adaptin Bio (APTN) Shares Outstanding (Diluted Average) (2022 - 2026)

Adaptin Bio has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $8.7 million for Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 49.34% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (up 49.34% YoY) and the FY2025 annual result came in at $7.8 million, up 140.38% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $8.7 million in Q1 2026, from $7.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $8.7 million in Q1 2026 and bottomed at $3.2 million in Q1 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $5.0 million (2022), against an average of $5.4 million.
• Year-over-year, Shares Outstanding (Diluted Average) slumped 35.0% in 2024 and soared 140.38% in 2025.
• Adaptin Bio's Shares Outstanding (Diluted Average) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then slumped by 35.0% to $3.2 million in 2024, then surged by 140.38% to $7.8 million in 2025, then increased by 11.39% to $8.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $8.7 million, $7.8 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.